• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者的补充与替代医学——土耳其影响因素分析

Complementary and alternative medicine in cancer patients - analysis of influencing factors in Turkey.

作者信息

Malak Arzu Tuna, Karayurt Ozgül, Demir Emel, Yümer Aylin Sami

机构信息

School of Health Sciences, Canakkale Onsekiz Mart University, Canakkale, Turkey.

出版信息

Asian Pac J Cancer Prev. 2009;10(6):1083-7.

PMID:20192589
Abstract

OBJECTIVE

This cross-sectional and descriptive study analysed complementary and alternative medicine (CAM) practices of patients with cancer diagnoses and influencing factors.

METHODS

The subjects consisted of 55 cancer patients hospitalized in Canakkale State Hospital between November 2008 and March 2009 and who were willing to participate in the study. Research data were collected using a sociodemographic characteristics form regarding CAM practices of cancer patients and the Beck Hopelessness Scale (total points 20, rising with the degree of hopelessness). Written consent from the head physician of Canakkale State Hospital and verbal consents of the patients were obtained in order for the research to be performed. The data were analysed using the SPSS 13.0 program (numbers and percentages, chi-squared and Mann Whitney U tests).

FINDINGS

Of the patients (49.1% female and 50.9% male) 78.2% had been living with a cancer diagnosis for more than two years. Of the 23.6% of patients with breast cancer and 21.8% with lung cancer, 87.2% uses CAM (72.7% received alternative treatment and 65.5% complementary treatment). Alternative treatments apply herbal treatments concomitantly such as honey, garlic; balsam apple, iscum album, tar oil and 29.1% of them only use stinging nettle. As a complementary treatment; 60% of patients pray for healing and 16.4% of them have massage regularly. Patients explained that they were using the alternative medicine in order to mitigate effects of the disease, to prevent its recurrence, to increase blood values, to feel psychologically relieved; and they were using complementary medicine just to feel psychologically relieved. Of 60% patients chose not to share their CAM practice with doctors and nurses. 36.4% of them use CAM on friend advice, 20% under media influence, 36.4% on their own initiative and 21.8% under family influence. The satisfaction from CAM is 61.1%. The rate of those who find alternative medicine expensive is 21.8%. There is statistically no correlation between CAM practice and age, gender, marital status, location they live for a long time, education and financial status of patients (p>0.05). The average of total hopelessness score of patients is 8.09 +/- 2.59, there is no statistically meaningful correlation between hopelessness score average of patients who use CAM and who do not use (p>0.05).

CONCLUSION

The cancer patients in the study who live in Canakkale province and in its districts use CAM. CAM practice does not vary by selected sociodemographic characteristics and the hope level. It is important that the health care professionals (nurses, doctors, etc) should be conscious of CAM-drug interactions and notify the patients about the risk.

摘要

目的

本横断面描述性研究分析了癌症确诊患者的补充和替代医学(CAM)实践及其影响因素。

方法

研究对象为2008年11月至2009年3月期间在恰纳卡莱州立医院住院且愿意参与研究的55名癌症患者。研究数据通过一份关于癌症患者CAM实践的社会人口学特征表格以及贝克绝望量表(总分20分,绝望程度越高分数越高)收集。为开展本研究,获得了恰纳卡莱州立医院主任医师的书面同意以及患者的口头同意。数据使用SPSS 13.0程序进行分析(数字和百分比、卡方检验和曼-惠特尼U检验)。

结果

患者中女性占49.1%,男性占50.9%,78.2%的患者已被诊断患有癌症超过两年。在23.6%的乳腺癌患者和21.8%的肺癌患者中,87.2%使用CAM(72.7%接受替代治疗,65.5%接受补充治疗)。替代治疗同时使用草药治疗,如蜂蜜、大蒜;苦瓜、白千层、焦油,29.1%的患者仅使用荨麻。作为补充治疗,60%的患者祈祷康复,16.4%的患者定期接受按摩。患者解释说,他们使用替代医学是为了减轻疾病影响、预防复发、提高血液指标、获得心理安慰;而使用补充医学只是为了获得心理安慰。60%的患者选择不与医生和护士分享他们的CAM实践。其中36.4%的人根据朋友建议使用CAM,20%受媒体影响,36.4%出于自身主动,21.8%受家庭影响。对CAM的满意度为61.1%。认为替代医学昂贵的比例为21.8%。CAM实践与患者的年龄、性别、婚姻状况、长期居住地点、教育程度和经济状况之间在统计学上无相关性(p>0.05)。患者绝望总分的平均值为8.09±2.59,使用CAM和未使用CAM的患者绝望评分平均值之间在统计学上无显著相关性(p>0.05)。

结论

本研究中居住在恰纳卡莱省及其辖区的癌症患者使用CAM。CAM实践不因所选的社会人口学特征和希望水平而有所不同。医护人员(护士、医生等)应意识到CAM与药物的相互作用并告知患者相关风险,这一点很重要。

相似文献

1
Complementary and alternative medicine in cancer patients - analysis of influencing factors in Turkey.癌症患者的补充与替代医学——土耳其影响因素分析
Asian Pac J Cancer Prev. 2009;10(6):1083-7.
2
Quality of life and complementary and alternative medicine use among cancer patients in Turkey.土耳其癌症患者的生活质量与补充和替代医学的使用情况
Eur J Oncol Nurs. 2009 Sep;13(4):287-94. doi: 10.1016/j.ejon.2009.03.007. Epub 2009 Apr 22.
3
The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey.土耳其癌症患者使用补充和替代(非传统)医学的情况。
Eur J Oncol Nurs. 2005 Jun;9(2):138-46. doi: 10.1016/j.ejon.2005.03.010.
4
Use of Complementary and Alternative Medicine and Quality of Life of Cancer Patients: Turkish Samples.补充替代医学的使用与癌症患者的生活质量:土耳其样本
Holist Nurs Pract. 2016 Mar-Apr;30(2):88-95. doi: 10.1097/HNP.0000000000000121.
5
Use of complementary and alternative medicine by patients with cancer in northern Turkey: analysis of cost and satisfaction.土耳其北部癌症患者使用补充和替代医学的情况:成本和满意度分析。
J Clin Nurs. 2012 Mar;21(5-6):677-88. doi: 10.1111/j.1365-2702.2011.03732.x. Epub 2011 Jun 30.
6
Complementary and Alternative Medicine Use Among Cancer Patients and Determination of Affecting Factors: A Questionnaire Study.癌症患者补充和替代医学的使用情况及影响因素的确定:一项问卷调查研究
Holist Nurs Pract. 2015 Nov-Dec;29(6):357-69. doi: 10.1097/HNP.0000000000000113.
7
Patterns of the use of complementary and alternative medicine in women with metastatic cancer.转移性癌症女性使用补充和替代医学的模式。
Cancer Nurs. 2010 May-Jun;33(3):194-200. doi: 10.1097/NCC.0b013e3181c295ac.
8
Investigation of usage, attitudes toward complementary and alternative medicine among cancer patients in Turkey during the COVID-19 pandemic1.1. 新冠疫情大流行期间土耳其癌症患者对补充替代医学的使用和态度调查
Work. 2024;78(4):1161-1172. doi: 10.3233/WOR-230195.
9
Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.尼日利亚埃努古市尼日利亚大学教学医院癌症患者使用补充和替代医学的情况。
BMC Complement Altern Med. 2007 Sep 12;7:28. doi: 10.1186/1472-6882-7-28.
10
Complementary/alternative medicine use in a pediatric oncology unit in Turkey.土耳其一家儿科肿瘤病房中补充和替代医学的使用情况。
Pediatr Blood Cancer. 2007 May;48(5):540-3. doi: 10.1002/pbc.21012.

引用本文的文献

1
Leaf Infusion Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Cisplatin Treatment.叶浸液增强三阴性乳腺癌细胞对顺铂治疗的敏感性。
Pharmaceuticals (Basel). 2023 May 23;16(6):780. doi: 10.3390/ph16060780.
2
Complementary, Traditional and Spiritual Practices Used by Cancer Patients in Turkey When Coping with Pain: An Exploratory Case Study.土耳其癌症患者应对疼痛时使用的补充、传统和精神疗法:一项探索性案例研究。
J Relig Health. 2021 Aug;60(4):2784-2798. doi: 10.1007/s10943-021-01276-9. Epub 2021 May 14.
3
Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.
补充与替代医学与乳腺癌患者:一例死亡病例及乳腺癌患者使用模式的系统评价
Plast Surg (Oakv). 2017 Nov;25(4):275-283. doi: 10.1177/2292550317716126. Epub 2017 Aug 22.
4
Medicinal Plants from Near East for Cancer Therapy.用于癌症治疗的近东药用植物。
Front Pharmacol. 2018 Jan 31;9:56. doi: 10.3389/fphar.2018.00056. eCollection 2018.
5
Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study.实体瘤患者补充与替代医学的使用及其与情绪状态和生活质量的关联:一项横断面研究
J Altern Complement Med. 2017 May;23(5):362-369. doi: 10.1089/acm.2016.0289. Epub 2017 Apr 28.
6
Predictors of complementary and alternative medicine use in cancer care: results of a nationwide multicenter survey in Korea.癌症治疗中补充和替代医学使用的预测因素:韩国全国多中心调查的结果。
Evid Based Complement Alternat Med. 2012;2012:212386. doi: 10.1155/2012/212386. Epub 2012 Dec 24.
7
Knowledge and attitudes towards complementary and alternative medicine among medical students in Turkey.土耳其医学生对补充和替代医学的知识和态度。
BMC Complement Altern Med. 2012 Aug 3;12:115. doi: 10.1186/1472-6882-12-115.